Company: NIVFW
Filing Date: 2025-08-22
Form Type: DRS
Source: 0001213900-25-079717
Chunk: 125

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-22
Form: DRS
Chunk 125
---
 US$ |           |     |      |         |
| - Payable less than 1 years         |     |              |   111,321 |     |      | 209,303 |
| - Payable 1 – 2 years               |     |              |    10,300 |     |      | 111,613 |
| - Payable 2.- 5 years               |     |              |         — |     |      |  10,373 |
| Total                               |     |              |   121,621 |     |      | 331,289 |
| Finance; lease                      |     |              |           |     |      |         |
| Lease liabilities – current portion |     |              |         - |     |      |   6,446 |
| -                                   |     |              |           |     |      |         |
| Convertible bonds-                  |     |              |           |     |      |       - |
| 2025                                |     |              |   516,250 |     |      |       - |
| 2026                                |     |              |   457,250 |     |      |       - |
| 2027                                |     |              |   457,250 |     |      |       - |
| 2028                                |     |              |   507,250 |     |      |       - |
| 2029                                |     |              | 3,269,625 |     |      |       - |
| Total                               |     |              | 5,207,625 |     |      |         |

The convertible bonds have
the option of being converted to Class A ordinary shares at the discretion of the holder, any time after issuance. The conversion, however,
is subject to certain terms and conditions, including the requirement of the shareholdings not to exceed 9.99% of the Company’s
shares. As of December 31, 2024, this criterion has been met.

Off-Balance Sheet Commitments and Arrangements

NewGenIvf has not entered
into any financial guarantees or other commitments to guarantee the payment obligations of any third parties, nor any derivative contracts
that are indexed to its shares and classified as shareholder’s equity or that are not reflected in its consolidated financial statements.
Furthermore, NewGenIvf does not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves
as credit,